Lipedema Evolution 2025

1. Lipedema Evolution 2025 Congress

• The Beauty of Lipedema — Opening LectureOpening lecture of the Lipedema Evolution 2025 Congress. Dr. Alexandre Amato presents lipedema as a female evolutionary advantage: peripheral fat as an energy reserve and a form of protection, the role of hormonal triggers (menarche, pregnancy, menopause) and the inflammation of the modern world as the true villain. He also addresses the myths behind the staging images used to frighten patients and why hypocaloric diets do not work.22min
• Defining Lipedema's Molecular HallmarksDr. Karen Herbst (Roxbury Institute, Tucson, USA) presents the multi-omics study published in 2025 with 121 blood samples and biopsies from patients in stages 1 to 3. RNA-seq, proteomics and lipidomics show increased oxidative phosphorylation, mitochondrial respiration and adiponectin and — surprisingly — suppressed immune activation in adipose tissue, raising new questions about inflammation, ceramides and glutathione supplementation. Lecture in English.20min
• Ultrasound in the Diagnosis of LipedemaDr. Keller da Silva Santos details the ultrasonographic protocol developed at Instituto Amato since 2018. He presents the 4 measurement points (thigh, pretibial, lateral leg and supramalleolar), the diagnostic cut-off values, the technique for avoiding compression bias and the differentiation between lipedema, lymphedema, lipolymphedema and lipomas. Includes a live hands-on ultrasound demonstration, reporting tips and guidance on equipment.18min
• Ultrasonographic Morphological Classification of LipedemaDr. Deise Vargas presents, for the first time, the ultrasonographic morphological classification of lipedema — a new proposal that complements the measurement protocol with a qualitative reading of the dermis and hypodermis. She details inflammation grades 1 to 4 (from the initial disruption of the septa to the marbled appearance with verticalization), the recognition of echogenic nodules and the differentiation from obesity, panniculitis and lymphedema. Includes the launch of the morphological changes calculator.20min
• Epidemiology and Prevalence of Lipedema in BrazilDr. Ana Paula Peclat discusses the modern epidemiology of lipedema, going beyond simple case counting: the biological, cultural, social and institutional determinants that keep the disease invisible. She presents the only Brazilian prevalence study (12.3%, Amato et al.), the 8.8 million women affected, the absence of any record in DATASUS and in the ICD, and what Brazil needs to do — inclusion of ICD-11 code EF02.2, primary care protocols and Ministry of Health guidelines.15min
• Vascular Approach to the Patient with LipedemaDr. Rodrigo Kikuchi addresses the vascular assessment and management of the patient with lipedema, including its relationship with varicose veins, the indications and contraindications for procedures, and the specific care this patient profile requires.20min
• Genetics of LipedemaDr. Daniel Benitti takes a deep dive into the genetics of lipedema: autosomal dominant inheritance with incomplete penetrance, the recurrent polymorphisms (AKR1C1, PPAR-γ, BUB1, PLIN1, MTHFR, HLA-DQ2/DQ8, VEGFA, GRB14), the prevalence of gluten intolerance, the role of the extracellular matrix and collagen, hyperpotent mitochondria, gluteofemoral fat as a cardiovascular protective factor, and why hormone replacement is a challenge in these patients.45min
• Systemic Manifestations of LipedemaDr. Daniel Benitti shows why lipedema is not a local disease of the fat but a systemic condition. From head to toe, he reviews the associated manifestations: hair loss from iron and vitamin D deficiency, melasma, anemia (41%), Hashimoto's thyroiditis (35%), polycystic ovary syndrome (20%), varicose veins (72%), hypermobility, pain, fluid retention, spontaneous bruising, and the differences between estradiol alpha and beta receptors in adipose tissue.40min
• Outpatient Micro-Liposuction in LipedemaDr. Mariana Silva (Centro de Lipedema Curitiba) presents the three surgical modalities her team performs: complete lipedema reduction surgery (360°), the intermediate Smart Fat Lipo and outpatient micro-liposuction. She details indications, the tumescent technique, local anesthesia or intravenous sedation, associated technologies (Morpheus, 1470 nm laser, power-assisted liposuction, Renuvion, argon plasma), the compression protocol and why conservative treatment should precede surgery by at least one year.30min
• Hormone Pellets and MenopauseDr. Igor Padovesi (gynecologist, menopause certified practitioner) offers a measured view on the most controversial topic in contemporary gynecology: hormone pellets. He reviews the history of the boom, the response of the medical societies, the available publications (including series with more than 1.2 million insertions), the real problems (lack of robust evidence, overuse, supraphysiological testosterone peaks) and the scenarios in which estradiol and testosterone implants have a legitimate role. Lecture recorded in Barcelona.30min
• Pycnogenol in the Treatment of LipedemaDr. Brenno Seabra and Dr. José Marcelo Corassa present the results of a double-blind randomized trial with 100 patients evaluating the use of Pycnogenol (Flebon) in lipedema. They review the mechanisms of the flavonoid — NF-κB blockade, capillary stabilization, reduced oxidative stress, browning of adipose tissue, perilipin modulation — and show the results: significant improvement in QuASiL (quality of life), a trend toward reduced body fat percentage and improved self-esteem at 8 weeks.25min
• Physical Therapy in the Rehabilitation of the Patient with LipedemaDr. Mariana Vita Milazzotto (Instituto Amato, for 12 years) reviews the role of physical therapy across the three fronts of treatment: conservative, intraoperative and postoperative. She details the four pillars for reducing pain and edema (manual lymphatic drainage, compression therapy, exercise and skin care), the anatomy of the lymphatic system as applied to correct technique, the use of vibration platforms and aquatic exercise, and day-to-day postoperative practice including the early identification of complications and active listening.30min
• Pressotherapy and Laser in Conservative TreatmentDr. Laura Alves explores two core technologies of the conservative treatment of lipedema. On pressotherapy, she discusses chamber types, safe parameters (30-60 mmHg), why consumer-market devices are unsuitable and the importance of combining it with manual lymphatic drainage. On photobiomodulation, she presents the evidence for laser and LED in adipocyte apoptosis, mitochondrial regeneration and cortisol modulation, and the ILIB technique (laser over the radial artery). Includes critical caveats on radiofrequency, microfocused ultrasound and cryolipolysis in inflamed tissue.35min
• Clinical Diagnosis of LipedemaDr. Alexandre Amato shows that the diagnosis of lipedema is primarily clinical — history taking and physical examination are enough. He presents the published screening questionnaire (86-91% accuracy), the differential criteria against lymphedema, obesity, Dercum's disease and panniculitis, the crucial distinction between the pitting sign (fluid) and diascopy (inflammation), the pitfalls of lymphoscintigraphy, why CT and MRI do not help in the initial diagnosis, and when DEXA or ultrasound are genuinely worth ordering.25min
• Clinical Cases in Office PracticeThree presentations of real cases of conservative treatment of lipedema by Dr. Renan Candemil (Tubarão, SC), Dr. Haila Almeida (São Paulo) and Dr. Ana Paula Peclat (Rio de Janeiro). Each case details the history, examination, bioimpedance, multidisciplinary management, supplementation (Pycnogenol, resveratrol, omega-3, curcumin, quercetin), vascular physical therapy and follow-up at 30-60 days — including the 'six pillars' model with its follow-up metrics.30min
• Conservative Treatment of LipedemaA guiding lecture by Dr. Daniel Benitti on the full arsenal of the conservative treatment of lipedema. From the pathophysiological reasoning (tissue hypoxia, microangiopathy, the vicious cycle of inflammation) to practical prescribing: recommended laboratory tests (including anti-Müllerian hormone, transferrin saturation, homocysteine, leptin, genetic testing), compression therapy and Linfopress, phytotherapeutic agents (horse chestnut, Ruscus, Centella, rutin, Pycnogenol, quercetin, boswellia, curcumin, omega-3, aminaftone), mitochondrial support (liposomal CoQ10, PQQ, carnitine, creatine) and how to structure the plan on a Monday morning in the office.55min
• Aesthetic Treatment in LipedemaDr. Vitor Gornatti (Prime Care / Instituto Lipedema Brasil) presents a structured approach to the aesthetic treatment of lipedema as an integral — not accessory — part of care. He covers the therapeutic pyramid (systemic support → topical agents → non-invasive technologies → advanced procedures), the three types of laxity (dermal, adipose, muscular), the role of collagen and glycation, and the comparative indications for non-ablative laser, microfocused ultrasound, injectable biostimulators, and monopolar and bipolar radiofrequency with microneedling.35min
• Lipedema and GestrinoneDr. Paula Frederich (nutrologist, founder of ABRALI — the Brazilian Association of Patients with Lipedema) offers a technical and measured view of the so-called 'beauty chip'. She explains what gestrinone is as a synthetic progestin derived from 19-nortestosterone, its heterogeneous mechanisms in the endometrium and in adipose tissue, its regulatory status at ANVISA, the actual indications (endometriosis, uterine myomatosis, PMDD, benign breast disease) and why lipedema is NOT a formal indication for its use on its own. A personal lecture from a physician who is herself a lipedema and cancer patient.25min
• Tumescent Liposuction in Lipedema (Germany)Dr. Stefan Rapprich, a German dermatologist, board member for the German lipedema guidelines and the person who taught the Brazilian team (Amato and Benitti) to operate on lipedema, shares more than 30 years of experience. He presents the concept of three sequential procedures per leg (inner, outer, lower) at 4-week intervals, the tumescent anesthesia technique with up to 9-10 liters, power-assisted (PAL) and water-jet liposuction, open postoperative drainage, and why the German guideline dropped the staging system. Lecture translated from English.25min
• Arm Lipedema and the Lipo 360 TechniqueDr. Ana Carolina Nadai (plastic surgeon) presents her topographic classification of arm lipedema — published at the 1st World Congress in Potsdam — dividing it into four types (upper arm, whole arm, iatrogenic and with skin laxity) plus a system for measuring laxity. She details her scarless Lipo 360 technique: 360° circumferential undermining that takes advantage of Langer's lines of tension (1861) to achieve physiological skin retraction, avoiding traditional brachioplasty. She shows cases and warns about the current wave of complications caused by surgeons without experience in this region.25min
• Vascular Complications and Thrombosis in LipedemaDr. Eduardo Ramacciotti (vascular surgeon and researcher) addresses venous thromboembolism (DVT + pulmonary embolism) in lipedema. He reviews the pathophysiological basis of the interaction between inflammation and thrombosis — the role of P-selectins and of leukocytes as an indispensable scaffold for clot formation — and presents the only robust retrospective study, covering 11 million US hospital admissions, showing an odds ratio of ~1.5 for DVT in patients with lipedema. Practical recommendation: apply the Caprini Score before every lipedema surgery and avoid combined procedures.20min
• Food Intolerance and Systemic InflammationDr. Paulo Grimaldi (Escola Paulista de Medicina, orthomolecular/integrative medicine) explains the difference between food allergy (IgE, rapid reaction) and food intolerance (IgG, delayed hypersensitivity over 4-6 days). He describes the anatomy of the tight junctions of the small intestine, how poorly digested proteins become antigens, the antigen-antibody cascade, and the relationship with dysbiosis and chronic disease. He presents IgG intolerance testing and the results of more than 10,000 patients analyzed in Brazil — with cow's milk, grains and eggs at the top of the list.25min
• Gut Health and LipedemaDr. Alexandre Amato argues that lipedema is, to a large extent, an intestinal symptom. He explains how endotoxins (lipopolysaccharides) escape the gut through a leaky gut, migrate preferentially to gluteofemoral adipose tissue in a 'pseudo-pregnancy state' and trigger a local inflammatory cascade that the complement system (with reduced factor D) is unable to resolve. He addresses the role of HLA-DQ2/DQ8 as an amplifier via zonulin and gluten, why 61% of patients are HLA positive and why eliminating gluten resolves 6 out of 10 cases. A warning against diagnostic 'early closure'.30min
• Cardiopulmonary Exercise Testing and Energy ProductionDr. Juliano Nadai (sports medicine, Scientific Council of the SBME) presents the metabolomic reasoning behind physical exercise in lipedema. He distinguishes physical activity from physical exercise, explains ATP production in the mitochondria, the aerobic and anaerobic thresholds assessed by cardiopulmonary exercise testing, the role of lactate and the bicarbonate buffer, and how to use bioimpedance to infer muscle fiber type (I vs II) and calibrate the training load without worsening edema. He closes with practical examples, urinary biomarkers (adipate/suberate) and the concept that 'the more sedentary you are, the less energy the body needs'.35min
• Contraception and LipedemaDr. Juliana Amato (gynecologist) presents preliminary data from the first Brazilian study on the impact of contraceptive methods in lipedema (148 women, Amato-Benitti Group). She reviews the protective role of estradiol in adipose tissue (lipolysis, anti-inflammatory action, gynoid distribution) and the altered alpha and beta receptors in lipedema. Practical hierarchy: first choice, copper or silver IUD or barrier methods; second choice, hormonal IUD (Kyleena/Mirena); third, low-dose pills; avoid subdermal implants and the vaginal ring. She warns about the average 13 kg weight gain reported.25min
• Q&A Session — Closing PanelFinal question block of day one of Lipedema Evolution 2025, with Dr. Paula Frederich, Dr. Juliana Amato, Dr. Juliano Nadai and Dr. Alexandre Amato. Topics include drospirenone and thrombogenic risk, the progestin-only mini-pill, the Mirena vs Kyleena IUD, tubal ligation in women with hypermenorrhea, osteoporosis and the use of Peptistrong, amino acid and whey protein supplementation, the difference between A1 and A2 milk (beta-casomorphin-7), daily creatine and its absorption with carbohydrate, muscle hyperplasia vs hypertrophy, and the reasoning behind managing overtraining in patients with lipedema.20min
• Molecular Bases and Nutrigenetics in LipedemaDr. Tatiane Fujii presents the molecular and nutrigenetic reasoning behind chronic inflammation in lipedema. She distinguishes physiological from pathological inflammation and details M1/M2 macrophage polarization, the role of Th2 lymphocytes and the gut-adipose tissue axis via LPS. She brings transcriptomic and metabolomic data from 72 women across 3 stages, the importance of IL-6 and MTHFR polymorphisms in the Brazilian population, and closes with practical measures: flavonoids (quercetin, catechins, anthocyanins), curcumin, omega-3, methylfolate and modulation of the estrobolome.30min
• High-Protein Nutrition and Muscle GainDr. Danilo Dib discusses why preserving (or gaining) muscle mass is essential in the treatment of lipedema and how to structure a high-protein diet compatible with a caloric deficit. He reviews myokines vs adipokines (the transient, anti-inflammatory role of muscle-derived IL-6), the feedback loop between diet, exercise, sleep and inflammation, the correct calculation of basal metabolic rate using the Mifflin-St Jeor equation, the distribution of 1.6-2.2 g/kg of protein across 3-5 meals, and the biological value of animal vs plant proteins (with praise for rice and beans).25min
• Ketogenic Diet in LipedemaDr. Alexandre Amato argues for the ketogenic diet as the non-invasive intervention with the strongest lipedema-specific evidence. He reviews the meta-analysis of 7 studies and 329 women, the multiple mechanisms (reduced CRP/TNF-α/IL-6, inhibition of the NLRP3 inflammasome, lower insulin, direct modulation of adipose tissue), the intriguing lymphangiogenesis documented in an animal model and the Lundanes study showing a 45% drop in CRP independent of weight loss. Clinical cases with results of up to 50 kg and 11 liters of volume reduction.30min
• GLP-1 as a Possible Treatment for LipedemaRecorded lecture by Dr. Thomas Wright (Laser Lipo Vein Center, St. Louis, USA) — phlebologist and one of the first 200 surgeons board-certified by the American Board of Phlebology. He reviews the pharmacology of GLP-1 and GIP agonists and their pleiotropic effects on metabolism, the cardiovascular system, the liver and adipose tissue, and presents preliminary data from his group showing reductions in weight, visceral fat, leg pain and tenderness to touch in patients with lipedema after 6 weeks of tirzepatide. Lecture in English with translation.20min
• Physical Exercise and LipedemaDr. Alexandre Amato presents the golden rule: in the presence of inflammation, you do not gain muscle mass and you do not lose fat — full stop. He distinguishes 'tense fat' (inflamed) from 'flaccid fat' (non-inflamed and metabolically available), details the vicious aesthetic cycle, the 30% quadriceps muscle deficit and its consequences (genu valgum, chondromalacia), and structures a prescription based on the QuASiL: aquatic exercise, light walking, yoga and tai chi in the inflamed phase; unrestricted progression in the non-inflamed phase, always avoiding HIIT, CrossFit and electrostimulation during active inflammation.25min
• Q&A — Nutrition, Ketogenic Diet and GLP-1Question block with Dr. Tatiane Fujii and Dr. Danilo Dib. They discuss flavonoids within a ketogenic diet (substitution with teas and tinctures), calculating protein requirements from current vs ideal body weight, the challenge of nutrition in patients using tirzepatide/semaglutide (aggressive caloric deficit, maintaining protein intake and baseline carbohydrate) and the role of the dietitian in this new pharmacological scenario.10min
• Mast Cell Activation SyndromeDr. Alexandre Amato presents MCAS (Mast Cell Activation Syndrome) as the 'second major trigger' of lipedema, alongside gut health. He explains the concept of the mast cell as a hyperactive 'watchdog', the evolutionary logic behind its high prevalence (up to 17%), the multisystem symptoms (dermatological, gastrointestinal, respiratory, neurological), histamine intolerance due to DAO deficiency, the connection with Ehlers-Danlos syndrome and POTS, and first-line treatment: H1/H2 blockade (loratadine, famotidine), cromolyn, quercetin, a low-histamine diet — and why one must NEVER operate during a mast cell crisis.30min
• Mental Health and Stigma in LipedemaDr. Valléria Roque (psychologist, lymphatic therapist, founder of APL — Apoio e Prevenção do Lipedema, in Portugal) shares her personal journey: 12 doctors, 7 surgeries, 11 years until diagnosis, 'she gave up on herself at 44 and was reborn at 50'. She presents the first Portuguese study (200 patients), showing 83.4% with symptoms of depression, anxiety, panic attacks, social isolation and emotionally driven eating disorder — as well as the overlap with ADHD (confirmed by Dr. Amato's 2023 study). An invitation to a humanistic perspective in the consultation.30min
• Legal Rights of the Patient with LipedemaDr. Gabrielle Brandão (attorney specializing in medical law, OAB-Itaquera) reviews the legal rights of patients with lipedema in Brazil. She addresses ICD-11 recognition and the CFM opinions, why the ANS list of covered procedures is illustrative rather than exhaustive, the difference between clinical and surgical treatment in litigation, how to build a robust medical report to obtain an injunction, the ANS route versus going straight to the courts, and the professional's role in informing patients of their rights before and after a denial of coverage.25min
• A Three-Phase Care PathwayDr. Alexandre Amato proposes a practical model of lipedema care in three sequential phases. Phase 1: bring down the inflammatory peak (diet, medication, lifestyle change). Phase 2: identify and remove the inflammatory triggers (self-knowledge, the hardest work of all). Phase 3: volume reduction (this is where surgery comes in). He shows why operating at the inflammatory peak produces the worst postoperative courses and why operating at the trough delivers far better results. He also presents the laboratory work-up for the first consultation, highlighting the inexpensive and little-known urinary indican as a marker of leaky gut.30min
• The Bright Side of LipedemaClosing lecture by Dr. Daniel Benitti with a shift in perspective: despite the brutal impact on quality of life (body image worse than in patients with paralysis, elevated risk of depression and suicide), there are measurable benefits in lipedema. He reviews Dr. Karen Herbst's study showing a lower risk of diabetes, hypertension and dyslipidemia even at a BMI of 35, the BMJ 2020 meta-analysis of 2.5 million people (larger hips and thighs = protection against mortality), JAMA 2023 (what matters is distribution, not weight) and the concept of body roundness. 'Either you awaken through pain, or you progress through love.'30min
• Closing of the CongressClosing remarks by Dr. Alexandre Amato at the end of Lipedema Evolution 2025. A thank-you to all participants, a reflection on what the congress delivered — 'more than science, it was empathy, listening, evolution' — and an invitation to spread this knowledge responsibly, because 'lipedema is gradually ceasing to be invisible'.5min
• Live Pós-Congresso — Lipedema Evolution 202551min